These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

940 related items for PubMed ID: 20021521

  • 1. The effect and safety of the antithrombotic therapies in patients with atrial fibrillation and CHADS score 1.
    Lee BH, Park JS, Park JH, Park JS, Kwak JJ, Hwang ES, Kim SK, Choi DH, Kim YH, Pak HN.
    J Cardiovasc Electrophysiol; 2010 May; 21(5):501-7. PubMed ID: 20021521
    [Abstract] [Full Text] [Related]

  • 2. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.
    Jacobs LG, Billett HH, Freeman K, Dinglas C, Jumaquio L.
    Am J Geriatr Pharmacother; 2009 Jun; 7(3):159-66. PubMed ID: 19616184
    [Abstract] [Full Text] [Related]

  • 3. Predictors of warfarin use in atrial fibrillation patients in the inpatient setting.
    Agarwal S, Bennett D, Smith DJ.
    Am J Cardiovasc Drugs; 2010 Jun; 10(1):37-48. PubMed ID: 20104933
    [Abstract] [Full Text] [Related]

  • 4. Risk of major bleeding with concomitant dual antiplatelet therapy after percutaneous coronary intervention in patients receiving long-term warfarin therapy.
    DeEugenio D, Kolman L, DeCaro M, Andrel J, Chervoneva I, Duong P, Lam L, McGowan C, Lee G, DeCaro M, Ruggiero N, Singhal S, Greenspon A.
    Pharmacotherapy; 2007 May; 27(5):691-6. PubMed ID: 17461704
    [Abstract] [Full Text] [Related]

  • 5. Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials.
    Flaker GC, Gruber M, Connolly SJ, Goldman S, Chaparro S, Vahanian A, Halinen MO, Horrow J, Halperin JL, SPORTIF Investigators.
    Am Heart J; 2006 Nov; 152(5):967-73. PubMed ID: 17070169
    [Abstract] [Full Text] [Related]

  • 6. Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation.
    Hylek EM, Go AS, Chang Y, Jensvold NG, Henault LE, Selby JV, Singer DE.
    N Engl J Med; 2003 Sep 11; 349(11):1019-26. PubMed ID: 12968085
    [Abstract] [Full Text] [Related]

  • 7. Comparison of bleeding in patients with nonvalvular atrial fibrillation treated with ximelagatran or warfarin: assessment of incidence, case-fatality rate, time course and sites of bleeding, and risk factors for bleeding.
    Douketis JD, Arneklev K, Goldhaber SZ, Spandorfer J, Halperin F, Horrow J.
    Arch Intern Med; 2006 Apr 24; 166(8):853-9. PubMed ID: 16636210
    [Abstract] [Full Text] [Related]

  • 8. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter.
    Cairns JA, Connolly S, McMurtry S, Stephenson M, Talajic M, CCS Atrial Fibrillation Guidelines Committee.
    Can J Cardiol; 2011 Apr 24; 27(1):74-90. PubMed ID: 21329865
    [Abstract] [Full Text] [Related]

  • 9. Relation of effective anticoagulation in patients with atrial fibrillation to stroke severity and survival (from the National Acute Stroke Israeli Survey [NASIS]).
    Schwammenthal Y, Bornstein N, Schwammenthal E, Schwartz R, Goldbourt U, Tsabari R, Koton S, Grossman E, Tanne D.
    Am J Cardiol; 2010 Feb 01; 105(3):411-6. PubMed ID: 20102959
    [Abstract] [Full Text] [Related]

  • 10. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke.
    Mohr JP, Thompson JL, Lazar RM, Levin B, Sacco RL, Furie KL, Kistler JP, Albers GW, Pettigrew LC, Adams HP, Jackson CM, Pullicino P, Warfarin-Aspirin Recurrent Stroke Study Group.
    N Engl J Med; 2001 Nov 15; 345(20):1444-51. PubMed ID: 11794192
    [Abstract] [Full Text] [Related]

  • 11. Bleeding during antithrombotic therapy in patients with atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators.
    Arch Intern Med; 1996 Feb 26; 156(4):409-16. PubMed ID: 8607726
    [Abstract] [Full Text] [Related]

  • 12. Association of warfarin use with CHADS(2) score in 441 patients with nonvalvular atrial fibrillation and no contraindications to warfarin.
    Desai HV, Aronow WS, Gandhi K, Bakerywala S, Laimuanpuii J, Sharma M, Peterson SJ.
    Prev Cardiol; 2010 Feb 26; 13(4):172-4. PubMed ID: 20860640
    [Abstract] [Full Text] [Related]

  • 13. Factors affecting bleeding risk during anticoagulant therapy in patients with atrial fibrillation: observations from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.
    DiMarco JP, Flaker G, Waldo AL, Corley SD, Greene HL, Safford RE, Rosenfeld LE, Mitrani G, Nemeth M, AFFIRM Investigators.
    Am Heart J; 2005 Apr 26; 149(4):650-6. PubMed ID: 15990748
    [Abstract] [Full Text] [Related]

  • 14. [The randomized study of efficiency and safety of antithrombotic therapy in nonvalvular atrial fibrillation: warfarin compared with aspirin].
    Hu DY, Zhang HP, Sun YH, Jiang LQ, Antithrombotic Therapy in Atrial Fibrillation Study Group.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Apr 26; 34(4):295-8. PubMed ID: 16776915
    [Abstract] [Full Text] [Related]

  • 15. Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: the HAS-BLED (Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs/Alcohol Concomitantly) score.
    Lip GY, Frison L, Halperin JL, Lane DA.
    J Am Coll Cardiol; 2011 Jan 11; 57(2):173-80. PubMed ID: 21111555
    [Abstract] [Full Text] [Related]

  • 16. Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation.
    Hansen ML, Sørensen R, Clausen MT, Fog-Petersen ML, Raunsø J, Gadsbøll N, Gislason GH, Folke F, Andersen SS, Schramm TK, Abildstrøm SZ, Poulsen HE, Køber L, Torp-Pedersen C.
    Arch Intern Med; 2010 Sep 13; 170(16):1433-41. PubMed ID: 20837828
    [Abstract] [Full Text] [Related]

  • 17. Compliance with antithrombotic prescribing guidelines for patients with atrial fibrillation--a nationwide descriptive study in Taiwan.
    Lin LJ, Cheng MH, Lee CH, Wung DC, Cheng CL, Kao Yang YH.
    Clin Ther; 2008 Sep 13; 30(9):1726-36. PubMed ID: 18840379
    [Abstract] [Full Text] [Related]

  • 18. [Atrial fibrillation and thromboembolic events prevention. State of the art].
    Matteoli S, Trappolini M, Chillotti FM.
    Minerva Cardioangiol; 2001 Feb 13; 49(1):1-13. PubMed ID: 11279381
    [Abstract] [Full Text] [Related]

  • 19. Combination therapy with aspirin, clopidogrel and warfarin following coronary stenting is associated with a significant risk of bleeding.
    Khurram Z, Chou E, Minutello R, Bergman G, Parikh M, Naidu S, Wong SC, Hong MK.
    J Invasive Cardiol; 2006 Apr 13; 18(4):162-4. PubMed ID: 16729401
    [Abstract] [Full Text] [Related]

  • 20. Net clinical benefit of antithrombotic therapy in patients with atrial fibrillation and chronic kidney disease: a nationwide observational cohort study.
    Bonde AN, Lip GY, Kamper AL, Hansen PR, Lamberts M, Hommel K, Hansen ML, Gislason GH, Torp-Pedersen C, Olesen JB.
    J Am Coll Cardiol; 2014 Dec 16; 64(23):2471-82. PubMed ID: 25500231
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 47.